- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/20 - Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
Patent holdings for IPC class A61K 47/20
Total number of patents in this class: 2263
10-year publication summary
|
152
|
167
|
208
|
210
|
224
|
299
|
264
|
263
|
278
|
156
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 106 |
40 |
| Eagle Pharmaceuticals, Inc. | 99 |
33 |
| Chugai Seiyaku Kabushiki Kaisha | 1357 |
30 |
| Hisamitsu Pharmaceutical Co., Inc. | 786 |
22 |
| Arcturus Therapeutics, Inc. | 170 |
20 |
| Heron Therapeutics, Inc. | 154 |
18 |
| Arcutis Biotherapeutics, Inc. | 106 |
18 |
| Hanmi Pharm. Co., Ltd. | 570 |
16 |
| The Board of Regents of the University of Texas System | 2204 |
15 |
| Eagle Biologics, Inc. | 19 |
15 |
| Comera Life Sciences, Inc. | 32 |
15 |
| Hoffmann-La Roche Inc. | 3422 |
14 |
| Genentech, Inc. | 3980 |
14 |
| FUJIFILM Corporation | 29399 |
14 |
| Cmpd Licensing, LLC | 80 |
12 |
| Fennec Pharmaceuticals Inc. | 25 |
12 |
| Oculis Operations Sàrl | 35 |
12 |
| Janssen Biotech, Inc. | 1548 |
11 |
| NanoVation Therapeutics Inc. | 62 |
11 |
| Arbutus Biopharma Corporation | 177 |
10 |
| Other owners | 1911 |